STK, a new member of the hepatocyte growth factor receptor family, is the receptor for macrophage-stimulating protein (MSP), which acts on murine resident peritoneal macrophages. We established polyclonal and monoclonal antibodies against STK and characterized the structure of STK protein and STK expression on cells of the mononuclear phagocyte system. Western blotting showed that the STK transcript is translated into a single-chain precursor and then cleaved into a 165-kD disulfide-linked heterodimer composed of a 35-kD a-chain and a 144-kD /.?-chain. Western blotting detected STK protein on resident peritoneal macrophages, a target of MSP, and showed that it was autophosphorylated in cells stimulated by MSP. By flow cytometric analysis using a monoclonal anti-STK antibody, we showed that STK protein is expressed on restricted macrophage populations such as resident peritoneal macrophages, but not ONONUCLEAR phagocytes are derived from bone marrow hematopoietic stem cells. Their production is controlled by cytokines such as interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and macrophage colony-stimulating factor (M-CSF).'.' The complete absence of osteoclasts in the osteopetrotic (op/op) mutant mouse, which has no active M-CSF, shows that this cytokine is essential for stimulating the production of some lineages of mononuclear phagocyte^."^ Monocytes are released from the bone marrow into the circulation and then migrate into tissues and serous cavities, where they differentiate into heterogenous types of cells such as peritoneal macrophages, alveolar macrophages, Kupffer cells, and microgmacrophages is believed to be mediated by the microenvironments into which they migrate. However, the specific factors that account for this differentiation have not been identified.
Many markers have been developed to distinguish mono-M lia, 1.2.8. 9 The tissue-specific terminal differentiation of on exudate peritoneal macrophages or mononuclear phagocytes of the bone marrow, peripheral blood, spleen, or alveoli. Resident peritoneal macrophages were classified into two fractions according t o their reactivity with an anti-STK antibody and a marker antibody for macrophages: STKhigh-F4/80high cells and STK"eg'"'"-F4/80'"w cells. Acute exudative macrophages were all STK"'g'""e-F4/80'0W, but they gradually became predominantly STKhigh-F4/80high several days after entrance into the peritoneal cavity. These results showed that after monocytes migrate into the peritoneal cavity, they undergo terminal differentiation in the peritoneal microenvironment. This is the first evidence of tissue-specific terminal differentiation of peritoneal macrophages, and this terminal differentiation can be characterized by the expression of STK receptor tyrosine kinase. 0 1995 by The American Society of Hematology.
nuclear phagocytes from other leukocytes. For example, the F4/80 monoclonal antibody is specific for mouse macrophages."' However, specific markers for different types of macrophages are relatively uncommon. Blood monocytes can be distinguished from resident macrophages by peroxidase staining." The ectoenzyme 5'-nucleotidase is present on resident macrophages but is undetectable in thioglycollate-elicited macrophages." Specialized subpopulations, such as metallophilic macrophages of the spleen and subcapsular macrophages of lymph nodes, have specific combinations of reactivities to panels of antibodies to cell membrane antigens.' STK (stem cell-derived tyrosine kinase) is a novel receptor tyrosine kinase that belongs to the hepatocyte growth factor (HGF) receptor family." The STK gene is a murine homologue of the human RON gene.I4 The STK gene was first isolated from mouse hematopoietic stem cells, whereas the RON gene was isolated from a human keratinocyte cell line. The predicted amino acid sequence of the STK gene has a stretch of basic amino acids (KRRRR) in the extracellular domain that is characteristic of the putative proteolytic cleavage site, as is found in c-MET, c-SEA, and RON." This means that the STK transcript may be translated into a singlechain precursor and then cleaved into a mature protein of disulfide-linked heterodimer with an extracellular a-chain and a transmembrane P-chain with intrinsic tyrosine kinase activity.
Recently, we and others have identified STK/RON as the receptor for macrophage-stimulating protein (MSP) using STWRON-transfected cell lines.'"I7 MSP is an 80-kD serum protein belonging to the family of proteins characterized by a highly conserved triple disulfide loop structure (Kringle domain). The family includes prothrombin, plasminogen, urokinase, and hepatocyte growth factor."-" Proteins in this family are secreted as single-chain precursors that acquire biologic activity when they are cleaved by specific serine proteases. Pro-MSP, the single-chain precursor of MSP, is reported to be cleaved to a disulfide-linked cy0 heterodimer by serine proteases such as enzymes of the intrinsic coagula- tion cascade, nerve growth factor-y, and epidermal growth factor-binding ~rotein.'~." Proteins in this family are related to serine proteases, but some, like MSP and HGF, are enzymatically inactive. MSP was first shown to induce murine resident peritoneal macrophages to become responsive to the chemoattractant C5a.'5 Purified MSP also acts as a chemoattractant for resident peritoneal macrophages, causes shape changes and migration of macrophages, and stimulates macrophage ingestion of complement-coated erythrocytes." However, MSP does not act on exudative peritoneal macrophage~'~.'~ or blood monocyte~.~' These findings suggest that expression of the MSP receptor is precisely regulated in the mononuclear phagocyte system. Using a monoclonal anti-STK antibody as a marker for the MSP receptor, we showed that the expression of STK is restricted to some of the macrophage populations and that the STK protein is a good marker antigen to characterize tissue-specific terminal differentiation of peritoneal macrophages.
MATERIALS AND METHODS
Cells and mice. Cells and tissues were obtained from C57BL/6 mlce. Bone marrow cells were flushed from femurs with phosphatebuffered saline (PBS). Mononuclear ceils of peripheral blood were isolated by centrifugation with Lympholyte-M (Cedarlane Laboratories Ltd, Hornby, Canada). A spleen cell suspension was prepared by filtering cells through mesh. Peritoneal cells were obtained by lavage of the peritoneal cavity with 5 mL of PBS. Exudative peritoneal macrophages were obtained from mice at different intervals after an intraperitoneal injection of 40 p g of concanavalin A (Con A). To obtain alveolar macrophages, the thoracic cavity was opened, and the trachea was ligated and cannulated with a 22-gage catheter. Lungs were lavaged with a total volume of IO mL of warm PBS-0.6 mmol/L EDTA in l-mL aliquots. Cells were centrifuged and resuspended in Dulbecco's modified Eagle's medium (DMEM) contaimng gentamicin and 10% fetal bovine semm (FBS). Macrophages were purified by adherence to plastic after an overnight incubation at 37°C. The [L-3-dependent pro-B cell line BalF3" was cultured in serum-free medium containing 100 U/mL of recombinant murine Reagents. Mature MSP was purified from human plasma as described.'8 Pure recombinant human HGF was provided by Dr M. Ueda, Snow Brand CO Ltd (Ishibashi, Tochigi, Japan). Murine IL-3 was purified from the supernatant of COS cells transfected with murine IL-3 cDNA. IL-3 was used after titration. Sheep anti-mouse or anti-rat IgG conjugated with horseradish peroxidase (HRP) was obtained from Amersham International (Amersham, UK). Goat antirabblt IgG conjugated with HRP was from Promega Corporation (Madison, WI). Monoclonal anti-phosphotyrosine antibody (clone 4G10) was from Upstate Biotechnology lnc (Lake Placid, NY). The enhanced chemiluminescence (ECL) detection system was from Amersham. Protein G-Sepharose was from Pharmacia (Uppsala, Sweden). RPM1 1640 medium and DMEM were from Life Technologies (Grand Island, NY).
Generation of polyclonal and monoclonal antibodies against STK. Antiserum against STK was raised in rabbits by immunization with a KLH-conjugated synthetic polypeptide corresponding to the Cterminal 17 amino acids (amino acid residues 1362 to 1378) of STK protein. A partial cDNA containing the entire extracellular domain of STK was fused in-frame to a sequence of human IgGIFc. This STK.Fc chimeric cDNA was inserted into a modified expression vector with the SRa promoter and transfected into COS7 cells using diethyl arninoethyl (DEAE)-dextran. The STK.Fc chimeric protein was purified from the serum-free conditioned medium of transfected COS7 cells. Hybridomas were produced by fusion of p3UI mouse IL-3. ). Protein in cell lysates was immunoprecipitated with rabbit antiserum against the C-terminus of STK or anti-STK monoclonal antibodies. Immune complexes were collected on protein G-Sepharose (Pharmacia). Cell lysates and immunoprecipitates were boiled for 3 minutes at 100°C in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer with or without 5% 2-mercaptoethanol (2-ME; reduced or non-reduced condition), resolved by SDS-PAGE with 6.5% or 10% polyacrylamide as described by Laemmli.29 After electrophoresis, proteins were lransferred to nitrocellulose membranes (Nihon Millipore Ltd, Yonezawa, Japan), which were then probed with the indicated antibodies, and specific binding was detected using the enhanced chemiluminescence system (ECL; Amenham).
Cell surface biotinylation. BaF3Ivector and BaF3/STK cells were biotinylated using the ECL protein biotinylation system (Amersham). Briefly, 5 X IOh cells in PBS were labeled with biotinylation reagent on ice for 30 minutes. The reaction was stopped by removing the biotin solution, washing two times with PBS, and incubating for 10 minutes with Tris-buffered saline (20 mmol/L Tris-HCI pH 7.6, 150 mmol/L NaCI). Cells were solubilized with lysis buffer, and cell lysates were precleared with Pansorbin Cells fCaJbiochem CO, La Jolla, CA) and protein G-Sepharose. Protein in precleared cell lysates was immunoprecipitated with anti-STK monocJona1 antibodies. Immune complexes were collected and resolved by SDS-PAGE with 10% polyacrylamide, as described above. After electrophoresis, proteins were transferred to nitrocellulose membrane, probed with streptavidin-HRP, and visualized with the ECL sysrem.
In vitro tyrosine phosphorylation assays. BaF3/STK cells, incubated for 12 hours in the absence of IL-3, were used for the phosphorylation assay. BaF/STK cells at a concentration of 1 x IOh/mL were incubated with 1.3 nmol/L human MSP, 1.3 nmol/L human HGF, or 10% fetal calf serum (FCS; Summit, Ft. Collins, CO) at 37°C for 10 minutes. The cells were then solubilized with lysis buffer (SO mmol/L HEPES [pH 7.41, 1 % Triton X-100, 10% glycerol, 10 mmoVL sodium pyrophosphate, 100 mmol/L sodium fluoride, 4 mmol/L EDTA, 2 mmolL sodium orthovanadate, 50 pg/mL aprotinin, I mmolL. PMSF. 100 pmoVL leupeptin, 25 pmol/L pepstatin A), and STK was immunoprecjpitated wirh rabbit antiserum against 2) and 28 (lanes 3 and 4) . Immune complexes were separated on SDS-PAGE with 10% polyacrylamide under reducing conditions. transferred, and probed with streptavidin-HRP. (C) Western blots of STK expression on immunoprecipitates from lysates of BaF3lvector cells ( h e S 1, 3, and 5) and BaF3/STK cells (lanes 2.4, and 6 ) with rabbit antiserum against STK (lanes 1 and 21, monoclonal antibody 1B (lanes 3   and 4) . and monoclonal antibody 28
(lanes 5 and 6). Proteins ware separated on SDS-PAGE with 6.5% polyacrylamide under reducing conditions, transferred, and probed with rabbit antiserum against STK.
For 
RESULTS
Production of anti-STK monoclonal antibodies and characterizution of STK protein in BaF3/STK cells. Monoclonal antibodies were raised against the extracellular domain of STK, and two clones, designated l B (IgG2a K ) and 2B (IgG I K ) , were isolated. FACS analysis showed that both monoclonal antibodies reacted with BaFYSTK cells, a cell line expressing STK, but not with BaF3hector control cells (Fig I) . Rabbit antisera raised against a synthetic polypeptide corresponding to the STK C-terminus was used in the Westem blots. The rabbit antisera detected a 165-kD protein (p16SSTK) under nonreducing conditions, and 144-kD and 160-kD proteins under reducing conditions (Fig 2A) . Rabbit preimmune serum did not detect any STK proteins (data not shown). On the other hand, 35-kD and 144-kD proteins, but not 160-kD protein, were detected by cell surface biotinylation followed by immunoprecipitation with monoclonal antibodies (Fig 2B) . These data show that p16S"K is a disulfide-linked heterodimer composed of a 35-kD a-chain and (Fig 2C) .
MSP induces autr)plpl?o.sphorl.lution of STK P-chain in resident peritoneal macrophages. The STK P-chain of BaFY STK cells was phosphorylated in response to purified human plasma MSP, but not to recombinant human HGF, a protein with 45% sequence identity to MSP (Fig 3A) . FCS also induced STK P-chain phosphorylation, suggesting the presence of bovine pro-MSP or MSP in the serum. The basal level of autophosphorylation of the STK P-chain in BaFY STK cells may be due to the overexpression of STK ( Fig  3A) . The other protein in Fig 3A that was immunoprecipitated with rabbit antiserum against STK is the 160-kD putative cytoplasmic uncleaved single-chain STK precursor, which becomes functional only after cleavage to the disulfide-linked heterodimer. Predictably, addition of MSP did not cause phosphorylation of this protein (Fig 3A) . In murine resident peritoneal macrophages, which are known targets for MSP, STK was detected, and the P-chain was phosphorylated in response to purified human plasma MSP (Fig 3B) . In contrast to BaF3/STK cells, which overexpress STK. the 160-kD uncleaved STK precursor was not detected in murine resident peritoneal macrophages, which express physiological amounts of STK (Fig 3B) .
MSP cuuses shape changes in STK-expressing cells. MSP causes shape changes and increased motility in resident peritoneal macrophages." Sixty percent of the resident peritoneal macrophages showed elongated shapes l hour after the addition of MSP (Fig 4B) . Sixty-eight percent of BaF3/ STK cells also responded to MSP with shape changes, including ruffling, budding, and elongation (Fig 4D) . These changes were not detected in BaFYvector cells (data not shown). FACS analysis showed that STK protein is expressed on resident peritoneal macrophages, but not on mononuclear phagocytes from bone marrow, peripheral blood. spleen, or alveoli (Figs S and 6) . The percentage of positive cells in the bone marrow. peripheral blood, spleen, and alveoli was within the background level. As expected from these results, MSP stimulated the uptake of ElgMC3bi by resident peritoneal macrophages, but not by alveolar macrophages (Fig 7) or by splenic macrophages (data not shown). The percentage of peritoneal macrophages that ingested at least one erythrocyte was 2% in the absence of MSP and 27% in the presence of MSP.
Resident peritoneal macrophages showed two distinct staining patterns (Fig S, Table l (Table l) . Although the number of F4/80'"" macrophages was much less than STKh""-F4/80h"" macrophages, the combination of anti-STK and F4/80 antibody clearly showed heterogeneity of resident peritoneal macrophages. Inasmuch as F4/80 staining intensity is lower in blood monocytes and exudative macrophages than in resident macrophages,"' our results suggested that F4/80'"" macrophages might be recent arrivals from the circulation that had not yet matured into the STKhigi"F4/80'"~'' phenotype. This hypothesis was tested in the experiment described in the following section.
The peritonecrl tnncrophnge e.rpre.ssion of STK i s uprepilotecl during terrninrrl d#erenticrtion. To test our hypothesis that the maturation of peritoneal macrophages is associated with an increase in F4/80 antigen and the appearance of STK, we induced an acute inflammation in the peritoneal cavity by an intraperitoneal injection of Con A and analyzed the peritoneal cells by FACS (Fig 8) . At I hour after injection, there was a marked decrease in the number of peritoneal cells recovered by lavage (below 10% of that before injection). At 3 hours after injection, there was a large influx of granulocytes (74.2% of the peritoneal cells recovered by lavage) that were not stained with F4/80 or anti-STK antibody. At 6 hours after injection, macrophages were found in the peritoneal lavage (59.5%). They were stained with F4/80 at low intensity but did not react with anti-STK. Thereafter, there was a progressive increase in the number of cells that reacted with both antibodies, as well as the fluorescence intensity per cell for both antibodies. On day 6, the profile was comparable with that of the preinjection control.
Ultrastructurul peroxidase cytochemistn of STK"'"-F4/ resident macrophages are easily distinguished by the different localization patterns of endogenous peroxidase activity.
Resident macrophages show peroxidase activity in the nuclear envelope and rough endoplasmic reticulum, whereas exudative macrophages show activity in the primary lysosomes but not in the nuclear envelope or the rough endoplasmic reticulum.' Most of the STKhi@'-F4/80''igh macrophages in the steady state showed peroxidase activity in the nuclear envelope and rough endoplasmic reticulum (Fig 9A) . Some macrophages showed weak peroxidase activity, probably because of the process of cell sorting. STK"igh-F4/80h'Fh macrophages revealed ultrastructural characteristics of mature macrophages such as well-developed rough endoplasmic reticulum and prominent cytoplasmic projections and infoldings (Fig 9A) . On the other hand, most of the F4/80'"" macrophages (>95%) after an eliciting stimulus showed peroxidase activity in the lysosomal granules but not in the nuclear envelope or rough endoplasmic reticulum (Fig 9B) . Cytoplasmic processes of these cells were less prominent than those of resident macrophages. Localization of endogenous peroxidase and ultrastructural characteristics of these cells correspond to those of exudative macrophages recently migrated from the blood stream. Morphology data are of resident peritoneal cells gated as in logical effects of MSP on resident peritoneal macrophages suggested the presence of STK protein on these cells. To identify the expression of STK protein on hematopoietic cells, we generated polyclonal and monoclonal antibodies against STK.
By Western blotting using anti-STK antibodies, we showed that STK is a 165-kD disulfide-linked protein composed of a 35-kD a-chain and a 144-kD P-chain (Fig 2A  and B) . We also detected 160-kD protein (Fig 2A) . This protein may be the cytoplasmic single-chain precursor, because this protein was not detected by cell surface biotinylation ( Fig 2B) and was not phosphorylated by MSP stimulation (Fig 3) . Mature STK protein (~165''~) may be synthesized as a single-chain precursor (p16OSTK), and then cleaved into the mature form by proteolytic cleavage at the conserved proteolytic cleavage site (KRRRR) in the extracellular domain. This process is very similar to that of the HGF receptor (c-MET). In the case of the HGF receptor, proteolytic cleavage of the precursor takes place before the appropriate subcellular localization. Western blotting also demonstrated the presence of STK protein on resident peritoneal macrophages, a target of MSP (Fig 3B) . The MSP-induced stimulation of motile (Fig 4B) and phagocytic activity (Fig 7A) of resident peritoneal macrophages were associated with autophosphorylation of the STK &chain (Fig 3B) . These data confirmed that STK transduces the MSP signal.
As it does in resident peritoneal macrophages, MSP caused autophosphorylation of the STK protein and shape changes in STK-transfected BaF3 pro-B cells (Figs 3 and  4) . MSP also stimulated the cell migration of STKtransfected NIH/3T3 fibroblasts." These data suggested that the STK receptor activated by MSP can transduce signals for shape changes and cell motility in various types of cells. Moreover, in STK-transfected BaF3 or erythroid cells, activated STK receptor could transduce pleiotropic biological effects such as the stimulation or suppression of cell proliferation (A.I., T.S., unpublished data, February 1995).
Among the many macrophage populations surveyed in our FACS analysis, STK expression was detected on resident peritoneal macrophages. Our preliminary analysis showed F4180 that osteoclasts, members of the mononuclear phagocyte system, also express STK and that MSP stimulates bone resorbing activity of However, STK was not expressed on exudative peritoneal macrophages or mononuclear phagocytes of the bone marrow, peripheral blood, spleen, or alveoli (Figs 5 through 7) . On the other hand, F4/ 80 antigen, a marker cell surface antigen of monocytes and macrophages, is expressed on all mononuclear phagocytes."' M-CSF receptor, a receptor tyrosine kinase, is also expressed on almost all mononuclear phagocytes we examined (A.I., T.S., unpublished data, January 1995). Thus, the restricted expression of STK receptor tyrosine kinase in the mononuclear phagocyte system is very unique, and STK could be a good marker discriminating the heterogeneity of the mononuclear phagocyte system. MSP stimulates resident, but not exudative, peritoneal macrophages.'6 The FACS analysis presented here clarified that STK, the MSP receptor, is present on resident peritoneal macrophages, but not on exudative macrophages or peripheral blood monocytes (Figs 5, 6, and 8; Table l). By determining the STK and F4/80 phenotype of exudative macrophages on successive days after the eliciting stimulus, we established that the profile of the recent arrivals from the circulation into the peritoneal cavity is STK"ep"''"-F4/80'"" For personal use only. on November 11, 2017. by guest www.bloodjournal.org From and that within 6 days, they differentiate into STK"'F"-F4/ macrophages (Fig 8) . Ultrastructural peroxidase cytochemistry confirmed these findings (Fig 9) . STK"is"-F4/80h'g" macrophages showed a resident pattern of peroxidase localization. whereas STK"'~~'"'"-F4/80'"' macrophages showed an exudative pattern. Moreover. STKh'ph-F4/80h'"" macrophages cxhibited ultrastructural characteristics of mature macrophages, while STK"'F'""'-F4/80"'" macrophages exhibited those of exudative macrophages recently migrated from the blood stream. The upregulation of STK during differentiation is the first evidence of tissue-specific terminal differentiation of peritoneal macrophages. STK could be a good marker antigen to characterize this terminal differentiation. Even in the absence of an acute inflammatory stimulus, there is a steady-state influx of STKg'""'-F4/80'"" blood monocytes into the peritoneal cavity, which accounts for our detection of this phenotype in addition to the terminally differentiated STKh'g''-F4/80t''gh macrophages in the resident peritoneal cell population (Fig S. Table l ) . During an acute inflammation. MSP. one of the serum factors, might diffuse into the inflammation site of the peritoneal cavity and form a local MSP gradient. This gradient may mediate the focal accumulation of resident macrophages and activate these cells at the site of inflammation." During the early stage of inflammation, resident peritoneal macrophages may be activated by MSP to oppose pathogens, and subsequently, exudative peritoneal macrophages may undergo terminal differentiation and take their place.
The tissue-specific terminal differentiation of macrophages is believed to be mediated by the microenvironments into which they migrate. However, the specific factors that account for this differentiation have not been identified. We tried using in vitro culture of peripheral blood monocytes in the presence of various cytokines, such as M-CSF, GM-CSF, IL-3. and IL-6; however, we could not derive STK-positive macrophages in vitro (data not shown). Considering that STK is expressed on restricted macrophage populations, upregulation of STK on macrophages is thought to be regulated by some unknown, tissue-specific microenvironments. Therefore. STK could be a good marker also in investigating microenvironments critical to terminal diffcrentiation of macrophages.
